Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allos Therapeutics, Inc.
Biopharma firm's stockholder approve share exchange
June 22nd, 2005
Stockholders of Allos Therapeutics, Inc., (ALTH), voting at the company's 2005 Annual Meeting of Stockholders on May 18, 2005, approved the issuance of shares of the company's common stock upon exchange of shares of the company's Series A Exchangeable Preferred Stock sold to Warburg Pincus Private Equity VIII, L.P. and certain other investors in a financing transaction in March 2005. As a result of such approval, the company issued a total of 23,524,430 shares of common stock upon exchange of 2,352,443 shares of Series A Exchangeable Preferred Stock. After giving effect to the share exchange, the company now has approximately 54.7 million shares of...
Source: Physician Law Weekly (2005-06-22)
|
